Menarini becomes exclusive distributor for INVOKANA® (canagliflozin) and VOKANAMET® (fixed-dose combination of canagliflozin and metformin) in the UK

A. Menarini Farmaceutica Internazionale SRL (“Menarini”) has become the

This content is restricted to site members. If you are an existing user, please log in. New users may register below.

New User RegistrationChoose a Username*

First Name*

Last Name*

Email*

Confirm Email (this is also your username)*

Country*

Password*

Confirm Password*

Trust *

Job Title: Please state what is on your job description. ( You need to be a registered nurse/doctor/allied health professional) to be a member of Trend Diabetes)*

Registration number*

Region*

I confirm I’m a registered healthcare professional*

*Required field

About the author

Diabetes Nurse

PrevNext